Blood cancer study seeks to uncover transplant barriers

NCT ID NCT02677064

Recruiting now Knowledge-focused Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study tracks over 1,300 people with blood cancers like acute leukemia to see how many receive a stem cell transplant. Researchers want to understand the medical and personal reasons why some patients get this treatment while others do not. The goal is to identify barriers so more patients can access potentially life-saving transplants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute leukemia myelodysplastic syndrome myelofibrosis myeloproliferative neoplasm Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE LEUKEMIA NEWLY DIAGNOSED RELAPSED

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Hartford Healthcare Cancer Institute @ Hartford Hospital
RECRUITING

Hartford, Connecticut, 06102, United States
Lehigh Valley Health Network
ACTIVE_NOT_RECRUITING

Allentown, Pennsylvania, 18103, United States
Memorial Sloan Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States

Contact Email: •••••@•••••

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.